Stay updated on Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces the previous v3.4.2 on the page. This appears to be a minor administrative update to the documents listed.
    Difference
    0.0%
    Check dated 2026-03-12T20:31:48.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.4.2, replacing the previous v3.4.1. This is a minor metadata update and does not affect the study information or page usability.
    Difference
    0.0%
    Check dated 2026-02-12T02:45:01.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    New revision tag 'Revision: v3.4.1' appears, replacing the previous 'Revision: v3.4.0'. This update does not change study details, eligibility criteria, or results displayed on the page.
    Difference
    0.0%
    Check dated 2026-02-04T22:54:05.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Show glossary feature added to the page and metadata now includes Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The previous capitalization variants and the older Revision: v3.3.4 were replaced.
    Difference
    0.1%
    Check dated 2026-01-28T20:18:54.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4, with the page displaying Revision: v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-14T03:29:37.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Added a Locations section including Ontario. Removed Ontario Locations and the HHS Vulnerability Disclosure (revision 3.3.2 to 3.3.3).
    Difference
    0.1%
    Check dated 2025-12-23T17:31:14.000Z thumbnail image

Stay in the know with updates to Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial page.